Jove
Visualize
联系我们

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Patient specific quality assurance: The final safety net in radiotherapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Streamlining Paediatric Palliative Radiotherapy: A Case Study on Reducing Procedural Burden and Avoiding General Anaesthesia Using a Simulation-Free Radiotherapy (SF-RT) Protocol.

Journal of medical radiation sciences·2026
Same author

Digital safeguarding incidents in schools with and without smartphone policies: a cross-sectional study in England.

Child and adolescent mental health·2026
Same author

Eurocentric Bias in Dysmorphology and Medical Genetics Education.

American journal of medical genetics. Part A·2026
Same author

Review of current best practice in radiation oncology for older adults with cancer: Updates from the International Society of Geriatric Oncology (SIOG) Task Force.

Journal of geriatric oncology·2025
Same author

Deep Plane Technique for Male Facelift Surgery.

Facial plastic surgery : FPS·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 27, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.4K

用一个简单的基于知识的预测工具来提高宫支臂治疗计划的质量,用于OAR剂量 (D2cm).

Emily Flower1, Jonathan Sykes1, Emma Sullivan2

  • 1Sydney West Radiation Oncology Network, Westmead, New South Wales, Australia; School of Physics, University of Sydney, Sydney, Australia.

Brachytherapy
|June 9, 2023
PubMed
概括

简化基于知识的规划预测了宫支臂疗法中的危险器官剂量. 这种方法使优化自动化,改善计划质量并减少本地晚期宫癌患者的毒性.

关键词:
宫癌是发生在宫癌的原因之一.基于知识的规划 基于知识的规划计划质量 计划质量

更多相关视频

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.4K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K

相关实验视频

Last Updated: Jul 27, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.4K
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

15.4K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.4K

科学领域:

  • 辐射瘤学 辐射瘤学
  • 医学物理 医学物理
  • 在瘤学瘤学.

背景情况:

  • 宫支臂疗法毒性与危险器官 (OAR) D2cm3 (剂量为2cm3) 相对应.
  • 基于知识的规划 (KBP) 提供了优化支臂治疗计划的潜力.
  • 调查简化KBP用于预测OAR D2cm3对于减少毒性至关重要.

研究的目的:

  • 证明简化KBP的可行性,用于预测宫支臂治疗中的OAR D2cm3.
  • 评估KBP检测低于最佳计划的能力,并提高整体计划质量.
  • 为了自动化优化用于本地晚期宫癌的支臂疗法计划.

主要方法:

  • 叠加体积组图 (OVH) 方法用于确定OAR和CTV_HR之间的2cm3叠加距离.
  • 线性模型使用两个独立的患者数据集将OAR D2cm3与2cm3的重叠距离相关联.
  • 交叉验证比较模型性能;剂量缩放为一致的CTV_HR D90;预测D2cm3作为反向规划约束.

主要成果:

  • 平均膀D2cm3减少了2.9%.
  • 平均直肠D2cm3减少了14.9% (数据集1) 和6.0% (数据集2).
  • 平均sigmoid D2cm3减少了10.7% (数据集1) 和6.1% (数据集2);肠道D2cm3减少了4.1% (数据集1).

结论:

  • 简化KBP有效地预测D2cm3在宫支臂治疗中的OAR.
  • 这种方法可以自动化优化,从而提高计划质量.
  • 该方法对改善本地晚期宫癌的治疗结果有前途.